2 results
Approved WMOPending
The primary objective of this study is to evaluate the efficacy of SCH 503034800 mg TID PO in combination with PegIntron 1.5 *g/kg QW SC plus ribavirin (800 - 1400 mg/day) in previously untreated adult chronic hepatitis C (CHC) subjects infected…
Approved WMORecruiting
To assess the effects and costs of the use of the Australian Medical Sheepskin and usual care with regard to the prevention of sacral pressure ulcers in somatic nursing home clients, versus usual care only.